Elbow Replacement — Cost, Top Hospitals & Success Rates | MyMedicPlus

Total elbow replacement (TER), also called total elbow arthroplasty (TEA), is a major orthopaedic procedure in which the damaged surfaces of the humeroulnar joint are replaced with a prosthetic implant. The elbow is the most complex joint of the upper extremity, functioning simultaneously as a hinge joint (flexion–extension) and a pivot joint (pronation–supination through the proximal radioulnar joint). When arthritis, rheumatoid disease, or post-traumatic damage destroys the articular cartilage and bony architecture of the elbow, total replacement offers reliable pain relief and restoration of functional motion for patients in whom more conservative surgical options are insufficient.

The procedure is performed under general anaesthesia with the patient positioned in the lateral decubitus or supine position. Through a posterior approach, the triceps mechanism is elevated, the distal humerus and proximal ulna are exposed, and the damaged joint surfaces are resected using surgical guides. Intramedullary stems of the humeral and ulnar components are cemented into the respective bone canals, and a linking mechanism couples the two metal components through a polyethylene bushing — forming either a fully constrained (linked) or semi-constrained (loosely linked) construct. A radial head component may be added when the radial head requires resection.

Elbow replacement surgery carries specific activity restrictions that distinguish it from hip or knee replacement: the lifetime weight-lifting limit is typically under 1 kg for repetitive tasks and under 5 kg for single-effort lifting, reflecting the vulnerability of prosthetic elbow implants to mechanical loosening under high loads. This makes careful patient selection — favouring older, lower-demand individuals — critical to long-term implant survival. In appropriate patients, total elbow replacement provides outstanding pain relief and functional restoration, with 10-year prosthesis survival exceeding 85–90% in rheumatoid arthritis and approximately 75–80% in post-traumatic arthritis.

Total elbow replacement is most commonly performed for end-stage rheumatoid arthritis of the elbow, which destroys the articular cartilage, ligaments, and bone, leading to severe pain, instability, and loss of functional range of motion. Rheumatoid elbow disease accounts for approximately 60–70% of TEA procedures and yields the most predictable long-term outcomes. Post-traumatic arthritis following distal humeral fractures — particularly complex intra-articular fractures in elderly osteoporotic patients — is the second most common indication. In patients over 65 years of age with comminuted distal humeral fractures not amenable to fixation, acute total elbow replacement as primary treatment increasingly replaces attempted open reduction and internal fixation.

Other indications include primary osteoarthritis of the elbow (less common than at the hip or knee, but significantly disabling when severe), psoriatic arthritis, ankylosing spondylitis, elbow arthritis in the context of haemophilia, and failed prior elbow surgery including failed internal fixation of distal humeral fractures, failed interposition arthroplasty, and revision of previous elbow replacements. Tumour surgery occasionally requires elbow replacement when resection of the distal humerus or proximal ulna for bone tumours necessitates joint reconstruction using custom or modular oncology prostheses.

The ideal candidate for total elbow replacement is a patient over 60–65 years of age with severe elbow arthritis — confirmed on plain X-rays showing joint space obliteration, significant osteophytes, bone loss, or deformity — who has disabling pain, functional limitation, and has failed conservative management including physiotherapy, anti-inflammatory medications, corticosteroid injections, and, where appropriate, arthroscopic debridement. The patient must have realistic expectations regarding the strict postoperative activity restrictions that accompany elbow replacement, particularly the lifelong prohibition against heavy lifting and impact activities. Patients who can commit to these restrictions and have low physical demands — such as retired individuals, homemakers, or white-collar workers — are the strongest candidates.

Contraindications to elbow replacement include active infection (absolute contraindication), Charcot neuropathic arthropathy, severe soft tissue compromise or absent triceps function, and patients under 50–55 years of age with high physical demands or occupational requirements for heavy lifting, as the mechanical demands imposed on the prosthesis in this group lead to unacceptably high revision rates. Severe osteoporosis may compromise cement fixation of the intramedullary stems, and medically unfit patients unable to tolerate a 2–3 hour general anaesthetic are also poor candidates. These patients may benefit from alternative procedures such as fascial interposition arthroplasty or arthroscopic debridement.

Two principal designs of total elbow prosthesis are available, each with distinct mechanical properties and indications. Semi-constrained (loosely linked) implants — exemplified by the Coonrad-Morrey prosthesis and the Latitude system — couple the humeral and ulnar components through a metal pin with a polyethylene bushing that allows 6–8 degrees of 'laxity' in valgus-varus. This design permits the surrounding soft tissues to assist in stabilisation, reducing stress at the bone-cement interface and improving longevity. Semi-constrained implants are the most widely used design globally and are suitable for most elbow replacement indications. Unlinked (unconstrained) designs such as the Kudo or Souter-Strathclyde prosthesis rely entirely on intact collateral ligaments and soft tissues for stability, making them appropriate only when ligamentous anatomy is well preserved — primarily in rheumatoid arthritis without significant bone or ligament destruction.

The surgical approach is typically through the posterior elbow. The triceps-on (Bryan-Morrey or Van Gorder approaches) or triceps-reflecting techniques are used to maintain triceps function and avoid the most significant cause of postoperative morbidity — triceps weakness or detachment. The distal humerus is prepared using an intramedullary reamer and broach, and the ulna canal is similarly prepared. Bone cement (polymethylmethacrylate) is pressurised into both canals before implant insertion. The surgical time is typically 2–3 hours. Revision elbow replacement for failed primary implants is technically demanding, requiring specialised components, bone grafting, and experienced revision elbow surgeons.

Total elbow replacement delivers outstanding pain relief as its primary benefit. Published systematic reviews and long-term series report 85–95% of patients achieving excellent or good pain relief at five years. For patients with rheumatoid arthritis, functional improvement is particularly dramatic — most patients regain the ability to perform activities of daily living including personal hygiene, feeding, and light household tasks within 6–12 weeks of surgery. Restoration of a functional arc of motion (typically 30–130 degrees of flexion-extension) is achieved in the majority of cases. Patient-reported outcome measures including the Oxford Elbow Score, ASES elbow score, and DASH questionnaire consistently show significant improvements compared to preoperative status.

For elderly patients with acute comminuted distal humeral fractures, acute total elbow replacement compares favourably with open reduction and internal fixation: randomised controlled trial data (Frankle et al., JBJS 2003; Githens et al., JBJS 2019) demonstrate superior functional outcomes at two years for TEA in patients over 65, with lower rates of reoperation. Long-term implant survival at 10 years is approximately 85–90% for rheumatoid indications and 75–85% for post-traumatic indications, with mechanical loosening being the most common reason for revision. Surgeon experience is an important outcome predictor — centres performing more than 20 TEA procedures annually consistently report better outcomes and lower complication rates.

Elbow replacement carries a higher complication rate than hip or knee replacement, reflecting the surgical complexity of the joint and the challenge of achieving stable, durable fixation in a relatively small bone. The most serious complication is deep periprosthetic infection, which occurs in 2–7% of cases — higher than at other joints — and often requires two-stage revision with implant removal, antibiotic spacer placement, and delayed reimplantation. The ulnar nerve is at risk during the posterior approach; transient ulnar nerve palsy occurs in 5–10% of cases, presenting as numbness and weakness in the ring and little fingers, and most cases resolve within 3–6 months. Permanent ulnar nerve injury occurs in less than 2% of cases.

Mechanical loosening of the cemented components is a long-term concern, occurring in 10–15% of implants at 10–15 years and requiring revision surgery. Triceps insufficiency — weakness or detachment of the triceps mechanism — is the most disabling functional complication, impairing the ability to push, press, and extend against gravity. Periprosthetic fracture, bushing wear, and linkage failure are implant-related complications more common in high-demand or overweight patients. Wound healing problems occur more frequently in patients on long-term immunosuppression (such as those with rheumatoid arthritis on methotrexate or biologics), and temporary dose modification is often recommended perioperatively in consultation with the rheumatologist.

Following surgery, the arm is elevated in a padded posterior splint for 3–5 days to minimise swelling. Supervised physiotherapy begins at 1–2 weeks, initially focusing on passive and active-assisted range-of-motion exercises. The triceps mechanism requires careful rehabilitation — full active elbow extension against gravity is deferred for 6–8 weeks in cases where the triceps was reflected during surgery. Occupational therapy is initiated early to assist with activities of daily living using adaptive equipment. Most patients regain functional motion (approximately 100 degrees of flexion arc) by 6–8 weeks. The strict 1 kg repetitive and 5 kg single-effort weight restrictions must be clearly explained to the patient at every follow-up, reinforced by written information, as violation of these restrictions is the primary cause of premature mechanical loosening.

Follow-up appointments are scheduled at 2 weeks (wound review), 6 weeks (X-ray and motion assessment), 3 months, 6 months, and annually thereafter. Annual X-rays are performed to monitor for progressive radiolucent lines at the bone-cement interface (indicating loosening), periprosthetic fracture, and bushing wear. Patients should be educated to report any new-onset pain, swelling, warmth, or functional deterioration promptly, as these may indicate infection, loosening, or component failure. Patients on disease-modifying antirheumatic drugs (DMARDs) require coordinated perioperative management with their rheumatologist to balance infection risk against perioperative flares of rheumatoid disease.

Total elbow replacement is one of the more costly upper limb procedures due to the complexity of the implant, the technical demands on the surgical team, and the length of surgery and hospitalisation. In the United States, the total cost for a primary elbow replacement at a private hospital ranges from USD 35,000 to USD 65,000, inclusive of surgeon fees, anaesthesia, implant, hospitalisation, and inpatient rehabilitation. Revision elbow replacement is significantly more expensive. Insurance coverage varies widely; most patients with rheumatoid arthritis or documented post-traumatic arthritis can obtain authorisation from their insurer with appropriate documentation.

For patients seeking affordable, high-quality care internationally, India represents the most cost-effective destination for elbow replacement. Leading orthopaedic hospitals in Delhi, Mumbai, and Hyderabad — several of which hold JCI accreditation — offer total elbow replacement for USD 6,000–USD 10,000, including surgeon fees, implant costs, hospitalisation, and physiotherapy. Thailand (Bangkok) and Turkey offer costs of USD 8,000–USD 14,000 with internationally trained surgeons and modern infrastructure. Malaysia is another option at USD 7,000–USD 12,000. These savings of 60–80% make medical travel an attractive option for patients without insurance or those facing long NHS waiting times in the UK (typically 18–24 months for elective joint replacement). Patients should ensure the treating centre uses proven prosthesis brands (Coonrad-Morrey, Latitude, Discovery) rather than unfamiliar generics.

For patients with moderate elbow arthritis who are not yet candidates for replacement — or who are too young or too active for the strict restrictions that TEA imposes — several alternatives exist. Elbow arthroscopy with osteocapsular arthroplasty (debridement and capsular release) can reliably restore range of motion and reduce pain in osteoarthritis with preserved joint space, delaying the need for replacement by 5–10 years in selected patients. Interposition arthroplasty — insertion of a biological spacer (fascia lata or Achilles tendon allograft) between resurfaced joint surfaces — provides an intermediate option for younger patients with post-traumatic arthritis, preserving bone stock for future conversion to total elbow replacement if needed.

Non-surgical management with optimised disease-modifying therapy for rheumatoid arthritis has transformed the natural history of rheumatoid elbow disease — modern biologic agents (anti-TNF, IL-6 inhibitors, JAK inhibitors) have substantially reduced the prevalence of severe rheumatoid elbow disease requiring replacement. Intra-articular corticosteroid injections provide temporary relief (typically 3–6 months) and may be repeated. Hyaluronic acid injections have limited evidence in the elbow. Physical therapy with splinting for acute inflammatory flares and eccentric strengthening for chronic tendinopathy complement these medical approaches.